Delivery Order SPE2DB22D3301-SPE2DB26FX3TM
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,100.28 for Lyrica 300 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract ceiling value of $4,142.53. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,972.10 for 90 capsules of Lyrica 100 mg on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This non-set-aside, competitively awarded contract employs firm fixed price terms with an ultimate completion date of August 27, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 9, 2025, for the supply of Lyrica 200 mg capsules (90-count units). The contract is valued at $4,215.55 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. This award represents a non-set-aside, competitively awarded contract and serves as a child order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lyrica 50 mg capsules (90-count units) valued at $6,567.28. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified vendor. The order is to be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lyrica 100 mg capsules (90-count units) at a ceiling value of $1,260.77. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by August 1, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.22 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units). This firm fixed-price, non-set-aside contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,786.46 on July 18, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This contract was awarded on a firm fixed price basis with no set-aside designation, indicating competitive award conditions. The order is scheduled for completion by July 21, 2025, and is being funded through the Medical Supply Chain division of the Department of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.66 to AmerisourceBergen Drug Corp for the supply of Lyrica 200 mg capsules (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3TMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lyrica 200 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $2,013.45. This is a non-set-aside competitive award with an ultimate completion date of October 24, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement that extends through December 2026 and serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive range of medications, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across multiple therapeutic domains, from diabetes and neurological medications to pain management and specialty pharmaceuticals. This award reflects AmerisourceBergen's established role as a primary supplier within the DLA's pharmaceutical distribution network supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/23/25 |